Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AGL NYSE:AUNA NASDAQ:PSNL NASDAQ:SERA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAGLAgilon Health$1.07-1.4%$1.57$0.71▼$6.08$441.36M0.117.17 million shs4.52 million shsAUNAAuna$6.32-0.8%$6.30$6.05▼$9.24$467.74M2.2638,600 shs76,345 shsPSNLPersonalis$5.85-4.1%$5.53$2.83▼$7.79$518.78M1.761.05 million shs1.01 million shsSERASera Prognostics$3.10+1.0%$2.80$1.37▼$9.13$116.78M1214,184 shs44,671 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAGLAgilon Health-4.00%-11.11%+21.35%-49.88%-66.36%AUNAAuna+0.25%+0.25%+0.89%+0.73%-9.32%PSNLPersonalis+13.17%+19.84%+33.48%+1.50%+2.52%SERASera Prognostics0.00%-9.97%+37.67%+79.53%-59.28%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAGLAgilon Health$1.07-1.4%$1.57$0.71▼$6.08$441.36M0.117.17 million shs4.52 million shsAUNAAuna$6.32-0.8%$6.30$6.05▼$9.24$467.74M2.2638,600 shs76,345 shsPSNLPersonalis$5.85-4.1%$5.53$2.83▼$7.79$518.78M1.761.05 million shs1.01 million shsSERASera Prognostics$3.10+1.0%$2.80$1.37▼$9.13$116.78M1214,184 shs44,671 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAGLAgilon Health-4.00%-11.11%+21.35%-49.88%-66.36%AUNAAuna+0.25%+0.25%+0.89%+0.73%-9.32%PSNLPersonalis+13.17%+19.84%+33.48%+1.50%+2.52%SERASera Prognostics0.00%-9.97%+37.67%+79.53%-59.28%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAGLAgilon Health 2.11Hold$3.07188.40% UpsideAUNAAuna 2.33Hold$10.7069.30% UpsidePSNLPersonalis 3.00Buy$7.4226.78% UpsideSERASera Prognostics 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest SERA, AGL, AUNA, and PSNL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/8/2025PSNLPersonalisHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$8.508/20/2025AGLAgilon HealthSanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform$4.00 ➝ $1.408/15/2025AGLAgilon HealthJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$2.40 ➝ $1.108/14/2025AGLAgilon HealthRobert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$5.00 ➝ $1.008/6/2025PSNLPersonalisBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$6.008/6/2025AGLAgilon HealthBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetUnderweight$3.00 ➝ $1.508/6/2025AGLAgilon HealthBenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$4.00 ➝ $1.508/6/2025PSNLPersonalisHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$9.00 ➝ $8.507/9/2025AGLAgilon HealthEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetIn-Line$5.00 ➝ $3.00(Data available from 9/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAGLAgilon Health$6.06B0.07N/AN/A$1.14 per share0.93AUNAAuna$1.17B0.40$1.16 per share5.43$5.85 per share1.08PSNLPersonalis$84.61M6.13N/AN/A$2.87 per share2.04SERASera Prognostics$80K1,459.71N/AN/A$1.40 per share2.21Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAGLAgilon Health-$260.15M-$0.77N/AN/AN/A-5.35%-66.76%-17.47%11/6/2025 (Estimated)AUNAAuna$29.39M$0.887.188.00N/A5.49%15.14%3.60%11/18/2025 (Estimated)PSNLPersonalis-$81.28M-$1.28N/AN/AN/A-113.70%-47.57%-35.05%11/5/2025 (Estimated)SERASera Prognostics-$32.90M-$0.85N/AN/AN/A-30,306.48%-45.86%-34.31%11/5/2025 (Estimated)Latest SERA, AGL, AUNA, and PSNL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/19/2025Q2 2025AUNAAuna$0.13$0.33+$0.20$0.31$1.17 billion$309.00 million8/6/2025Q2 2025SERASera Prognostics-$0.21-$0.16+$0.05-$0.16$0.05 million$0.02 million8/5/2025Q2 2025PSNLPersonalis-$0.25-$0.23+$0.02-$0.23$20.12 million$17.20 million8/4/2025Q2 2025AGLAgilon Health-$0.11-$0.25-$0.14-$0.25$1.47 billion$1.39 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAGLAgilon HealthN/AN/AN/AN/AN/AAUNAAunaN/AN/AN/AN/AN/APSNLPersonalisN/AN/AN/AN/AN/ASERASera PrognosticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAGLAgilon HealthN/A1.161.16AUNAAuna1.710.910.84PSNLPersonalisN/A6.095.92SERASera PrognosticsN/A1.731.73Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAGLAgilon HealthN/AAUNAAunaN/APSNLPersonalis61.91%SERASera Prognostics54.64%Insider OwnershipCompanyInsider OwnershipAGLAgilon Health3.57%AUNAAunaN/APSNLPersonalis3.80%SERASera Prognostics13.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAGLAgilon Health1,076414.42 million399.63 millionNot OptionableAUNAAuna14,84274.01 millionN/AN/APSNLPersonalis40088.68 million85.31 millionOptionableSERASera Prognostics12037.67 million32.59 millionOptionableSERA, AGL, AUNA, and PSNL HeadlinesRecent News About These CompaniesInsider Selling: Sera Prognostics (NASDAQ:SERA) Director Sells 3,899 Shares of StockSeptember 11 at 9:29 PM | marketbeat.comSera Prognostics (NASDAQ:SERA) CFO Austin Aerts Sells 5,263 SharesSeptember 11 at 9:29 PM | marketbeat.comSera Prognostics (NASDAQ:SERA) CEO Sells $66,647.70 in StockSeptember 11 at 8:57 PM | marketbeat.comSera Prognostics (NASDAQ:SERA) Director Sandra Aj Lawrence Sells 3,899 SharesSeptember 10 at 7:51 AM | insidertrades.comSera Prognostics, Inc. (NASDAQ:SERA) Short Interest UpdateSeptember 9 at 11:40 AM | marketbeat.comSera Prognostics Highlights Strategy at Investment ConferenceSeptember 6, 2025 | msn.comSera Prognostics, Inc. $SERA Shares Purchased by AWM Investment Company Inc.September 5, 2025 | marketbeat.comGhisallo Capital Management LLC Makes New $368,000 Investment in Sera Prognostics, Inc. $SERASeptember 2, 2025 | marketbeat.comSERA PROGNOSTICS TO PRESENT AT H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCEAugust 28, 2025 | prnewswire.comAberdeen Group plc Invests $4.56 Million in Sera Prognostics, Inc. $SERAAugust 23, 2025 | marketbeat.comRobert Gardner Harrison Sells 6,000 Shares of Sera Prognostics (NASDAQ:SERA) StockAugust 21, 2025 | insidertrades.comSera Prognostics, Inc. (NASDAQ:SERA) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | msn.comSera Prognostics outlines European expansion and new commercial hires while targeting PreTRM Test reimbursement pilotsAugust 7, 2025 | msn.comSera Prognostics, Inc. (SERA) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comSera Prognostics (SERA) Q2 Loss Down 4%August 6, 2025 | fool.comSera Prognostics, Inc. (SERA) Reports Q2 Loss, Lags Revenue EstimatesAugust 6, 2025 | zacks.comSERA PROGNOSTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTSAugust 6, 2025 | prnewswire.comSera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2025 Financial Results on August 6, 2025July 29, 2025 | prnewswire.comSera Prognostics director Mirza sells $552 in stockJuly 10, 2025 | investing.comSera Prognostics (NASDAQ:SERA) Stock, Insider Trading ActivityJune 30, 2025 | benzinga.comSera Prognostics: PreTRM Labor Test Should Represent Advance In Risk AssessmentJune 30, 2025 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSERA, AGL, AUNA, and PSNL Company DescriptionsAgilon Health NYSE:AGL$1.06 -0.02 (-1.39%) Closing price 03:59 PM EasternExtended Trading$1.07 +0.01 (+0.47%) As of 05:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.Auna NYSE:AUNA$6.32 -0.05 (-0.78%) Closing price 03:59 PM EasternExtended Trading$6.34 +0.02 (+0.30%) As of 04:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.Personalis NASDAQ:PSNL$5.85 -0.25 (-4.10%) Closing price 04:00 PM EasternExtended Trading$5.82 -0.03 (-0.51%) As of 05:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Personalis, Inc. develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD) and recurrence in cancer; and ImmunoID NeXT, a tissue-based test that combines whole exome (DNA) and whole transcriptome (RNA) sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for detection of MRD and recurrence in cancer; and NeXT Dx, a comprehensive tumor profiling test that unlocks the entire exome (DNA) and transcriptome (RNA) with matched tumor-normal analysis. In addition, the company performs whole exome sequencing (WES) of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing (WGS) on human samples for research projects, such as population sequencing initiatives, as well as offers sequencing and data analysis services to support population sequencing initiatives. Its customers include pharmaceutical companies, biopharmaceutical companies, diagnostics companies, universities, non-profits, government entities, and patients. The company was incorporated in 2011 and is headquartered in Fremont, California.Sera Prognostics NASDAQ:SERA$3.10 +0.03 (+0.98%) Closing price 04:00 PM EasternExtended Trading$3.10 0.00 (-0.16%) As of 04:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Not Just NVDA: 3 Semiconductor Stocks Struggling This Quarter Broadcom Gets Big Upgrades: How High Analysts See Shares Going Why Micron Stock Could Outperform NVIDIA in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
